CLINICAL_TRIALS trial_result · 2015-03-19

Clinical Trial Update: Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar [Phase 2]

Phase 2 trial evaluating erlotinib in women with vulvar squamous cell carcinoma has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Dana-Farber Cancer Institute | Conditions: Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2015-03-19